Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort.

Breast Cancer Res Treat · 2015 · PMC4432026 · PMID 25940996

Europe PMC DOI

hedged sentence

0.0512

closest p · 1.0× alpha

0.0512

boldest claim

The sentences

borderline significantp = 0.0512so close (0.05 < p ≤ 0.1)

indicated that taxane chemotherapy was associated with a borderline significant increase in risk of mild swelling compared to no chemotherapy (HR 1.31, p = 0.0512), and a significant increase in risk of mild swelling compared to non-taxane chemotherapy (HR 1.86, p = 0.0398).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.